Sonoma Pharmaceuticals, Inc.
SNOA
$1.11
-$0.03-2.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 25.13% | 11.75% | 12.46% | -8.57% | 27.27% |
| Total Depreciation and Amortization | 6.45% | 3.03% | 2.86% | -7.69% | -24.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -181.65% | -378.57% | 12.60% | -204.93% | 989.66% |
| Change in Net Operating Assets | -14.07% | -93.09% | -134.91% | -456.52% | -70.93% |
| Cash from Operations | -446.32% | -235.22% | -279.38% | -120.94% | -162.50% |
| Capital Expenditure | 38.30% | -2,250.00% | 61.54% | -2,020.00% | -361.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 38.30% | -2,250.00% | 61.54% | -2,020.00% | -361.11% |
| Total Debt Issued | 1.09% | -- | -- | -- | -26.54% |
| Total Debt Repaid | 37.04% | 31.71% | 31.97% | 31.93% | 13.83% |
| Issuance of Common Stock | 228.57% | -66.33% | -98.66% | -96.95% | -85.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 59.92% | -70.34% | -104.29% | -109.12% | -61.09% |
| Foreign Exchange rate Adjustments | -102.63% | 212.39% | 148.41% | 258.91% | 154.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -217.39% | -140.93% | -138.28% | -228.20% | -80.89% |